CTGF emerges as a new target and is intensely studied because of its strong association with chronic inflammatory disorder, such as atherosclerosis, arthritis, inflammatory kidney, and neuroinflammatory diseases [25]. The gene discussed is CCN2; the disease is arthritic joint disease.